Endeavor Health is a U.S.-based, not-for-profit integrated health system serving the Chicago metropolitan area. Formed through the combination of NorthShore University HealthSystem and Edward-Elmhurst Health, it operates a network of acute-care hospitals, outpatient centers, and specialty care facilities.
The system provides comprehensive services spanning primary and specialty care, surgery, behavioral health, and emergency medicine. Endeavor Health also engages in clinical research and quality-improvement initiatives in collaboration with physicians and partners to advance patient care and outcomes.
Combination achieved up to 23.3% weight loss (54.1 lbs) and 2.9% A1C reduction versus 14.8% (34.4 lbs) and 2.4% with tirzepatide; Phase 3 to start Q4 2026.
Eloralintide led to significant weight loss and improved cardiometabolic factors in a Phase 2 trial, prompting Phase 3 studies for obesity treatment.
